BioHarvest Sciences Inc. (BHST)
NASDAQ: BHST · Real-Time Price · USD
2.030
-0.080 (-3.79%)
Aug 19, 2026, 4:00 PM EDT - Market closed
BioHarvest Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 35.48 | 34.51 | 25.19 | 12.67 | 5.5 | 2.1 | |
Revenue Growth | 17.51% | 37.00% | 98.77% | 130.48% | 161.56% | 430.81% |
Cost of Revenue | 14.56 | 14.03 | 11.25 | 7.04 | 4.28 | 1.43 |
Gross Profit | 20.91 | 20.48 | 13.94 | 5.63 | 1.22 | 0.67 |
Selling, General & Admin | 21.51 | 20.74 | 16.13 | 12.23 | 9.52 | 5.03 |
Research & Development | 5.79 | 5.31 | 4.8 | 3.37 | 2.31 | 4.13 |
Operating Expenses | 27.3 | 26.05 | 20.93 | 15.6 | 11.83 | 9.16 |
Operating Income | -6.38 | -5.58 | -6.99 | -9.97 | -10.61 | -8.49 |
Interest Expense | -2.04 | -2.72 | -1.24 | -0.94 | -0.51 | -0.81 |
Interest & Investment Income | 0.27 | 0.05 | - | - | - | - |
Currency Exchange Gain (Loss) | -1.83 | -1.83 | -0.08 | 0.03 | 0.23 | 0.29 |
Other Non Operating Income (Expenses) | -0.99 | -0.99 | -4.61 | -1.69 | -0.35 | -0.82 |
EBT Excluding Unusual Items | -10.98 | -11.06 | -12.91 | -12.56 | -11.24 | -9.83 |
Pretax Income | -10.98 | -11.06 | -12.91 | -12.56 | -11.24 | -9.83 |
Income Tax Expense | 0.1 | 0.08 | 0.01 | - | - | - |
Earnings From Continuing Operations | -11.07 | -11.14 | -12.91 | -12.56 | -11.24 | -9.83 |
Net Income | -11.07 | -11.14 | -12.91 | -12.56 | -11.24 | -9.83 |
Net Income to Common | -11.07 | -11.14 | -12.91 | -12.56 | -11.24 | -9.83 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 21 | 18 | 16 | 14 | 13 | 12 |
Shares Outstanding (Diluted) | 21 | 18 | 16 | 14 | 13 | 12 |
Shares Change | 21.61% | 13.69% | 19.66% | 3.67% | 4.87% | 28.15% |
EPS (Basic) | -0.53 | -0.60 | -0.80 | -0.93 | -0.86 | -0.79 |
EPS (Diluted) | -0.53 | -0.60 | -0.80 | -0.93 | -0.86 | -0.79 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -10.75 | -9.58 | -9.52 | -10 | -10.5 | -8.43 |
Free Cash Flow Per Share | -0.51 | -0.52 | -0.59 | -0.74 | -0.80 | -0.68 |
Gross Margin | 58.95% | 59.34% | 55.35% | 44.45% | 22.17% | 31.87% |
Operating Margin | -17.99% | -16.16% | -27.75% | -78.65% | -193.02% | -403.95% |
Profit Margin | -31.21% | -32.27% | -51.27% | -99.15% | -204.37% | -467.51% |
Free Cash Flow Margin | -30.31% | -27.77% | -37.79% | -78.88% | -190.92% | -401.24% |
EBITDA | -5.8 | -5.11 | -6.54 | -9.58 | -10.33 | -8.43 |
EBITDA Margin | -16.36% | -14.81% | -25.96% | -75.57% | -187.83% | - |
D&A For EBITDA | 0.58 | 0.46 | 0.45 | 0.39 | 0.29 | 0.07 |
EBIT | -6.38 | -5.58 | -6.99 | -9.97 | -10.61 | -8.49 |
EBIT Margin | -17.99% | -16.16% | -27.75% | -78.65% | -193.02% | - |